These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11485766)

  • 1. Antithrombotic effect of ticlopidine in an experimental model of retinal vein occlusion.
    Arroyo JG; Dastgheib K; Hatchell DL
    Jpn J Ophthalmol; 2001; 45(4):359-62. PubMed ID: 11485766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Yamamoto T; Kamei M; Yokoi N; Yasuhara T; Tei M; Kinoshita S
    Am J Ophthalmol; 2004 Nov; 138(5):809-17. PubMed ID: 15531317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis.
    Ameri H; Ratanapakorn T; Rao NA; Chader GJ; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1429-39. PubMed ID: 18642023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
    Squizzato A; Manfredi E; Bozzato S; Dentali F; Ageno W
    Thromb Haemost; 2010 Feb; 103(2):271-6. PubMed ID: 20126837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.
    Ageno W; Cattaneo R; Manfredi E; Chelazzi P; Venco L; Ghirarduzzi A; Cimino L; Filippucci E; Ricci AL; Romanelli D; Incorvaia C; D'Angelo S; Campana F; Molfino F; Scannapieco G; Rubbi F; Imberti D
    Thromb Res; 2010 Feb; 125(2):137-41. PubMed ID: 19477488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Masood I
    Am J Ophthalmol; 2005 Jul; 140(1):167; author reply 167. PubMed ID: 16038677
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosterone Exposure Causes Increased Retinal Edema and Severe Retinopathy Following Laser-Induced Retinal Vein Occlusion in Mice.
    Allingham MJ; Tserentsoodol N; Saloupis P; Mettu PS; Cousins SW
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3355-3365. PubMed ID: 30025072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinal vein occlusions in patients treated with anticoagulant and/or platelet aggregation inhibitors. Five case studies].
    Ducos de Lahitte G; Quintyn JC; Leparmentier A; Mathis A
    J Fr Ophtalmol; 2007 Feb; 30(2):145-9. PubMed ID: 17318096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute variations in retinal vascular oxygen content in a rabbit model of retinal venous occlusion.
    Jaime GR; Kashani AH; Saati S; Martin G; Chader G; Humayun MS
    PLoS One; 2012; 7(11):e50179. PubMed ID: 23185567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
    Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
    Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.
    Abdallah WF; Patel H; Grant EG; Diniz B; Chader GJ; Humayun MS
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6920-7. PubMed ID: 22969076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
    O'Brien M; Parness IA; Neufeld EJ; Baker AL; Sundel RP; Newburger JW
    Pediatrics; 2000 May; 105(5):E64. PubMed ID: 10799628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor outcomes despite aspirin or statin use in high-risk patients with retinal vein occlusion.
    Matei VM; Xia JY; Nguyen C
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):761-766. PubMed ID: 28004197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
    Abumiya T; Houkin K
    J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
    Sartori MT; Barbar S; DonĂ  A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
    Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin.
    Helft G; Osende JI; Worthley SG; Zaman AG; Rodriguez OJ; Lev EI; Farkouh ME; Fuster V; Badimon JJ; Chesebro JH
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2316-21. PubMed ID: 11031221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of fraxiparin and ticlid therapy of acute retinal vessels occlusion].
    Kasymova MS
    Vestn Oftalmol; 1998; 114(4):21-4. PubMed ID: 9771082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photocoagulation of the Retinal Nonperfusion Area Prevents the Expression of the Vascular Endothelial Growth Factor in an Animal Model.
    Gozawa M; Takamura Y; Miyake S; Matsumura T; Morioka M; Yamada Y; Inatani M
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5946-5953. PubMed ID: 29098298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
    Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
    Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.